Please assess the completion status of the following clinical trial:

Trial Title: Mifepristone and Two Doses of Misoprostol for Abortion at 11&12 Weeks

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Seeking medical abortion services at one of the enrolling clinics~* Have an intrauterine pregnancy 71-77 days of gestation or 78-84 days~* Meet standard eligibility criteria for medical abortion~* Be able to return to clinic for in-person follow up~* Speak/read/write English or Spanish~* Have access to a mobile phone with texting capability~* Be in general good health~* Be willing and able to sign consent forms~* Agree to comply with the study procedures and follow up.~Exclusion Criteria:~* Not eligible to consent on their own to being in a study (Age criteria may vary by site according to state law.)~* With known allergies or other contraindications to mifepristone or misoprostol~* Desiring to start depot medroxyprogesterone acetate (DMPA) as contraception method immediately because of potential interaction with mifepristone. Those who wish to wait until abortion completion to start DMPA will be eligible for enrollment.

- Gender: FEMALE
- Minimum Age: 11 Years
- Maximum Age: 55 Years
- Healthy Volunteers: t

Study Arms:
- 71-77 days of gestational age (Type: NO_INTERVENTION): Pregnant people whose pregnancies are estimated to have a gestational age of 71-77 days. (Participants in this arm receive the standard of care for medical termination of pregnancy in the stated gestational age range).
- 78-84 days of gestational age (Type: EXPERIMENTAL): Pregnant people whose pregnancies are estimated to have a gestational age of 78-84 days.

Based on this trial design, predict the completion outcome and termination type (if applicable).